{{Rsnum
|rsid=8040502
|Gene=CASC5
|Chromosome=15
|position=40622992
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.2994
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CASC5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 20.0 | 80.0
| HCB | 48.9 | 48.9 | 2.2
| JPT | 43.2 | 45.5 | 11.4
| YRI | 0.0 | 14.5 | 85.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 48.9 | 48.9 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{Venter SNP
|rsid=8040502
|allele=G
|frequency=0.892
|uid=1103645593460
|type=homozygous_SNP
|hugo=CASC5
|ensembl gene=ENSG00000137812
|ensembl transcript=ENST00000346991
|sift=
|disease=A chromosomal aberration involving CASC5 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with MLL/HRX. May give rise to a MLL-CASC5 fusion protein.
}}

{{ neighbor
| rsid = 33931006
| distance = 359
}}

{{GET Evidence
|gene=CASC5
|aa_change=Arg936Gly
|aa_change_short=R936G
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8040502
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=0
|n_articles_annotated=0
|nblosum100=6
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}